Clinical Trials Logo
  1. Home
  2. Sepsis Syndrome
  3. NCT03842371

Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis

Sepsis Syndrome Clinical Trial

Official title:
Metabolism of Branched-chain Amino Acids in Monocyte and Macrophage During Sepsis

Clinical Trial Summary

The current project was designed to examine the metabolic level of branched-chain amino acids in plasm and monocyte/macrophage, and its role in immune dysfunction during sepsis.

Clinical Trial Description

In this study, the investigators will collect the peripheral blood of 1,3,7,14 day after diagnose of sepsis. Then, the concentration of branched-chain amino acids(BCAAs) in monocytes and plasma, and the expression of BCAAs metabolic enzymes in monocytes will be determined. Additionally, the inflammatory cytokines, e.g., Interleukin-1β (IL-1β), Tumor necrosis factor-α (TNF-α), Interleukin-10 (IL-10）, the chemokines macrophage inflammatory proteins 1α and 1β (MIP-1α and 1β) in the peripheral blood and the phagocytic function of monocytes will also be detected. The current project was designed to examine the metabolic level of branched-chain amino acids in plasm and monocyte/macrophage, and its role in immune dysfunction during sepsis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03842371
Study type Observational
Source West China Hospital
Contact
Status Not yet recruiting
Phase
Start date February 11, 2019
Completion date February 28, 2022
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04560842 - The Efficacy of High-flow Nasal Cannula Oxygen Therapy in Sepsis Patients N/A
Completed NCT04475081 - Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis Phase 3
Completed NCT03314831 - The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
Completed NCT03371680 - Kinetics of Surfactant Proteins, Phosphatidylcholine and Body Water in Intensive Care Unit (ICU) N/A
Completed NCT00046072 - A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis Phase 2
Enrolling by invitation NCT05602584 - Effect of Immunophenotype on Prognosis of Sepsis
Completed NCT06338111 - Can we Improve Mortality Prediction in Patients With Sepsis in the Emergency Department
Completed NCT04292431 - Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP)
Recruiting NCT03472170 - Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote. N/A
Not yet recruiting NCT05382078 - Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
Recruiting NCT03956043 - Diagnostic Accuracy in Sepsis
Recruiting NCT05977153 - CT for Personalized Mechanical Ventilation N/A
Completed NCT00448968 - The Utility of Ischemia Modified Albumin (IMA) in Sepsis N/A
Completed NCT05246969 - Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
Not yet recruiting NCT06446947 - Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
Recruiting NCT05261607 - Analysis of the Evolution of Mortality in an Intensive Care Unit
Recruiting NCT04203979 - Sepsis: From Syndrome to Personalized Care
Recruiting NCT03990467 - Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU N/A
Recruiting NCT05338359 - Metrology to Enable Rapid and Accurate Clinical Measurements in Acute Management of Sepsis
Completed NCT02562261 - Platelet REactivity in Sepsis Syndrome (PRESS)